Global Trade Alert
Global Trade Alert

Back to state act

United States of America: Agreement with Amgen on Most-Favoured-Nation drug pricing and tariff exemption

Description

On 19 December 2025, the U.S. Administration announced an agreement with Amgen. Under the agreement, the U.S. Administration will delay the implementation of industry-specific tariffs on pharmaceutica...

Sign in to see full description

Intervention Details

Intervention Type

Local operations incentive

MAST Chapter

L: Subsidies (excl. export subsidies)

Implementation date

31 Jul 2026

Revocation date

20 Jan 2029

Implementation level

National

Affected flow

Inward

Announced as temporary

No

Eligible firms

firm-specific

Affected Trading Partners

Graph

Table

Affected Sectors

Sign in to access 1 sectors

Affected Products

Sign in to access 2 products

Threads

See all

This intervention is not part of any Thread yet.